Journal
JOURNAL OF HUMAN HYPERTENSION
Volume 26, Issue 6, Pages 396-404Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/jhh.2011.41
Keywords
flavonoids; anthocyanins; blood pressure; randomized controlled trial; physiological stress reactivity; cardiovascular diseases
Categories
Ask authors/readers for more resources
High intakes of flavonoids are associated with reduced cardiovascular risk, and flavonoids such as cocoa and soy protein isolate have shown beneficial effects on blood pressure (BP). Anthocyanins constitute a flavonoid subgroup consumed in regular diets, but few studies have assessed the antihypertensive potential of anthocyanins. We aimed to assess whether high concentrations of relatively pure anthocyanins reduce BP and alter cardiovascular and catecholamine reactivity to stress. A total of 31 healthy men between 35-51 years of age with screening BP > 4140/90 mm Hg, not on antihypertensive or lipid-lowering medication, were randomised in a double-blind crossover study to placebo versus 320-mg anthoycanins twice daily. Treatment duration was 4 weeks, with a 4-week washout. Sitting and supine BP measurements, ambulatory BP recording and stress reactivity were assessed and analyzed by a paired sample t-test. In all, 27 patients completed all visits. Sitting systolic BP (primary end-point) was 133 mm Hg after placebo versus 135 mm Hg after anthocyanin treatment (P = 0.25). Anthocyanins did neither affect semiautomatic oscillometric BP measurements in the sitting or supine position nor 24-h ambulatory BP. No significant differences in stress reactivity were found across treatment periods. Overall, we conclude that high concentrations of these relatively pure anthocyanins do not reduce BP in healthy men with a high normal BP. Journal of Human Hypertension (2012) 26, 396-404; doi:10.1038/jhh. 2011.41; published online 5 May 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available